Treatment Guidelines

American Thoracic Society Clinical Practice Guidelines

The American Thoracic Society (ATS) and the Japanese Respiratory Society (JRS), in conjunction with an ad hoc guideline development committee of LAM experts, prepared the following guidelines for the treatment of lymphangioleiomyomatosis. 

Read the Guidelines

To read the 2016 LAM Clinical Practice Guidelines, click here.
To read the 2017 LAM Clinical Practice Guidelines, CLICK HERE.

Continuing Medical Education

Lymphangioleiomyomatosis Evidence Based Practice, a new Continuing Medical Education (CME) Enduring Material activity, is now available through the joint providership of the University of Cincinnati and the RLDC for AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours), ABIM MOC Part 2 (1.00 hours). The course reviews the 2016 and 2017 ATS/JRS Clinical Practice Guidelines in addition to sharing clinical pearls from experienced LAM Clinic Directors.

This activity has been designed to meet the educational needs of pulmonologists, obstetricians and gynecologists, emergency room physicians, family medicine physicians, internal medicine physicians, nurse practitioners and physician assistants, and respiratory therapists involved in the management of patients with LAM. Clinicians can take the course and receive continuing education credits at no cost, for both CME and maintenance of certification (MOC).

Jointly provided by the University of Cincinnati and the Rare Lung Disease Consortium, this activity is supported by an independent educational grant from the UNC Eshelman Institute for Innovation as well as contributions from The LAM Foundation and the Rare Lung Disease Consortium.

To participate in this activity, please visit https://uc.cloud-cme.com/aph.aspx?EID=20754&P=3000&CaseID=2410.

To learn more about the American Thoracic Society, visit www.thoracic.org.

European Respiratory Society Treatment Guidelines

The European Respiratory Society, along with the ERS LAM Task Force, has put together the following guideline for the treatment of lymphangiomyoleiomatosis. An updated version of these guidelines highlighting the important scientific advances over the past few years is currently being drafted.

To view the guidelines, click here.

To learn more about the European Respiratory Society, click here.

This content was created for general informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.